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Background
The glyoxalase system is the main catabolic pathway of
methylglyoxal, a toxic 2-oxoaldehyde which occurs in all
living cells as a by-product of glycolysis [1,2]. Trypano-
somatids, such as Leishmania infantum, are pathogenic
microbial parasites which have glycolytic enzymes located
in a specific cell organelle, the glycosome [3]. In these
organisms, the usual glyoxalase cofactor glutathione is
functionally replaced by trypanothione [4,5]. Inhibition
of the glyoxalase pathway might cause the accumulation
of methylglyoxal in the glycosome, hampering glycolysis
and killing the parasite.
Methods
An ODE model of the glyoxalase pathway was developed
based on a kinetic characterization of the glyoxalase sys-
tem in L. infantum [6]. As depicted in Figure 1, it is
assumed that methylglyoxal is formed at a constant rate,
vin. Methylglyoxal reacts with one or both thiol groups of
trypanothione forming mono- or bis-hemithioacetals in a
reversible mass-action reaction. These hemithioacetals are
the substrates of the glyoxalase system, forming D-lactate
as final product and regenerating free trypanothione. vin is
the input flux of methylglyoxal in the pathway; v1 and v-1
are mass-action reaction rates; v2 and v3 are Michaelis-
Menten enzyme-catalysed reaction rates. Steady-state con-
centrations and their sensitivities were derived as func-
tions of glyoxalase I and II activities, methylglyoxal influx
and total thiol concentration [6]. Necessary mathematical
relations for the existence of a steady state were also calcu-
lated from the asymptotic behavior of these functions. All
mathematical relations are exact and were derived sym-
bolically using Mathematica® 4.0, from Wolfram
Research, Inc.
Results
Methylglyoxal concentration achieves a steady state only
when parameters remain within certain boundaries. Out-
side these boundaries, the typical dynamic behaviour of
the system is the depletion of free trypanothione, leading
to the accumulation of methylglyoxal over time. Total
cofactor concentration cannot be arbitrarily low, it must
exist above a defined threshold, the so-called "catalytic
amount". Enzyme activities must also be greater than a
threshold value, which is higher than the flux of the path-
way. Conversely, for constant enzyme activities, there is a
limit for methylglyoxal formation flux above which the
glyoxalase pathway can not prevent the accumulation of
methylglyoxal. Variations of enzyme activity have virtu-
ally no effect on methylglyoxal steady-state concentration
(sensitivity of approximately 0). The non-enzymatic
hemithioacetal formation has a sensitivity of -1. Methylg-
lyoxal concentration sensitivity to input flux and total
cofactor concentration are approximately 1 and -1, respec-
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Methylglyoxal steady-state concentration as a function of (a) total trypanothione concentration, (b) methylglyoxal formation rate, (c) glyoxalase I activity a d (d) gly x lase II activityFigure 2
Methylglyoxal steady-state concentration as a function of (a) total trypanothione concentration, (b) methylglyoxal formation 
rate, (c) glyoxalase I activity and (d) glyoxalase II activity. Parameters are normalized to reference values.
                                          
Glyoxalase pathway of L. infantumFigure 1
Glyoxalase pathway of L. infantum.
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tively. In the vicinity of the boundaries outside of which a
steady state is not attained, the absolute values of all sen-
sitivities rise to infinity. However, the reference parameter
values, which correspond to the physiological state of L.
infantum in exponential phase, are very far from the
boundaries – compared to the minimum values required
to attain a steady state, total cofactor is approximately
50,000 fold, glyoxalase I activity is approximately 23,000
fold, glyoxalase II activity is approximately 30,000 fold
and input flux is approximately 25,000 fold.
Conclusion
Decreasing the activity of the glyoxalase enzymes is
unsuitable to harm the parasite since no significant rise of
methylglyoxal steady-state concentration is achieved.
However, depletion of the cofactor trypanothione or the
enhancement of methylglyoxal production leads to a sig-
nificant increase of the concentration of this toxic com-
pound. These results point to a possible strategy for
treatment of leishmaniasis based on the interference with
trypanothione metabolism or glycolysis. This study pro-
vides quantitative data which might be useful for future
research on drug targeting this disease.
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